Thomas Sears - Publications
Affiliations: | Pathology | Northwestern University, Evanston, IL |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Drumm M, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb BT, Byrne KT, Unruh D, Thirunavu V, Walshon J, Steffens A, McCortney K, Lukas RV, Phillips JJ, et al. Postoperative risk of IDH mutant glioma-associated seizures and their potential management with IDH mutant inhibitors. The Journal of Clinical Investigation. PMID 37104042 DOI: 10.1172/JCI168035 | 0.425 | |||
2021 | Sears TK, Horbinski CM, Woolard KD. IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat. Journal of Neuro-Oncology. PMID 34424450 DOI: 10.1007/s11060-021-03829-0 | 0.414 | |||
2020 | Sandoval JA, Tomilov A, Datta S, Allen S, O'Donnell R, Sears T, Woolard K, Kovalskyy D, Angelastro JM, Cortopassi G. Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells. Pharmaceuticals (Basel, Switzerland). 13. PMID 33255358 DOI: 10.3390/ph13120419 | 0.471 | |||
Show low-probability matches. |